↓ Skip to main content

Dove Medical Press

Current status of poly(ADP-ribose) polymerase inhibitors and future directions

Overview of attention for article published in OncoTargets and therapy, October 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
4 X users
patent
5 patents
facebook
1 Facebook page

Citations

dimensions_citation
104 Dimensions

Readers on

mendeley
137 Mendeley
citeulike
1 CiteULike
Title
Current status of poly(ADP-ribose) polymerase inhibitors and future directions
Published in
OncoTargets and therapy, October 2017
DOI 10.2147/ott.s139336
Pubmed ID
Authors

Akihiro Ohmoto, Shinichi Yachida

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 137 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 18%
Researcher 23 17%
Student > Master 17 12%
Student > Bachelor 11 8%
Other 11 8%
Other 15 11%
Unknown 36 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 31 23%
Medicine and Dentistry 26 19%
Agricultural and Biological Sciences 13 9%
Chemistry 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Other 13 9%
Unknown 40 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#6,493,896
of 26,017,215 outputs
Outputs from OncoTargets and therapy
#318
of 3,040 outputs
Outputs of similar age
#93,340
of 334,911 outputs
Outputs of similar age from OncoTargets and therapy
#9
of 78 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,040 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,911 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.